Fig. 33From: The past, present and future of anti-malarial medicinesKey stages in the hit to lead pathway of MMV048. Initial replacement of the 3-methoxy-4-hydroxyphenyl moiety helped to improve in vivo stability and solubility. Further replacement of the methoxy group with a trifluoromethyl group improved potency and metabolic stability leading to the optimized compoundBack to article page